Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

Experts discuss South Africa’s current vaccine manufacturing capabilities and the steps needed to prepare for future ...

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...